BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03867084-completion@plaintrial.com
DTSTAMP:20261029T034806Z
DTSTART;VALUE=DATE:20250930
SUMMARY:Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Ad
 juvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Com
 plete Radiological Response After Surgical Resection or Local Ablation (MK
 -3475-937 / KEYNOTE-937) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03867084
URL:https://plaintrial.com/trial/NCT03867084
END:VEVENT
END:VCALENDAR